We are monitoring the impact of COVID-19 on Europe Ophthalmic Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5301
Share on
Share on

Europe Ophthalmic Drugs Market Research Report - Segmented By Therapeutic Class, Product Type, Distribution Channel, Disease Indication, Dosage Form, Technology and Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2020 to 2025)

Pulished: February, 2020
ID: 5301
Pages: 145

Europe Ophthalmic Drugs Market Size (2020 to 2025)

As per the research report, the size of the Europe Ophthalmic Drugs market size is valued at around USD 8.3 billion in 2020. It is expected to grow at a CAGR of 4.9% to reach USD 10.54 billion by 2025. It captures 25% of the global market share.

Ophthalmic drugs are used for the treatment of various eye disorders like cataract, glaucoma etc.

Increasing number of people suffering from glaucoma all over the world, high innovation in and heavy funding in the development of combination therapies are the major factors driving the growth of this market.

Adverse side-effects and long gestation periods in the development of new drugs are the factors hampering market growth.

This research report on the European market has been segmented and sub-segmented into the following categories:

  • By Therapeutic Class: Anti-inflammatory Drug, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-allergy Drugs, Anti-VEGF Agents, Others
  • By Product Type: Prescription Drugs, Over-the-Counter Drugs 
  • By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Independent Pharmacies & Drug Stores 
  • By Disease Indications: Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders, Allergy, Uveitis, Others  
  • By Dosage Form: Liquid Ophthalmic Drug Forms, Solid Ophthalmic Drug Forms, Semisolid Ophthalmic Drug Forms, Multicompartment Drug Delivery Systems, Other Ophthalmic Drug Forms       
  • By Technology: Biologics, Cell Therapy, Gene Therapy, Drug Delivery, Small molecule, Others 
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Regionally, Europe comes a close second however is likely to undergo sluggish growth till 2025. France is the leader in the European market.

Key players operating in the Europe Ophthalmic Drugs Market profiled in this report are Carl-Zeiss AG, Ellex Medical Lasers Ltd., Hoya Corporation, Novagali Pharma S A, Abbott Medical Optics, Inc., Essilor International S.A. Other players in the market include Insight Vision Inc., Nidek Co.Ltd, Topcon Corporation, and Ziemer Ophthalmic Systems AG.

  1. Introduction          
    1. Market Definition                    
    2. Study Deliverables                  
    3. Base Currency, Base Year and Forecast Periods   
    4. General Study Assumptions                
  2. Research Methodology                    
    1. Introduction        
    2. Research Phases                      
      1. Secondary Research           
      2. Primary Research 
      3. Econometric Modelling      
      4. Expert Validation  
    3. Analysis Design  
    4. Study Timeline   
  3. Overview                
    1. Executive Summary                
    2. Key Inferences  
    3. Epidemology       
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             
    1. Market Drivers   
    2. Market Restraints                    
    3. Key Challenges  
    4. Current Opportunities in the Market       
  5. Market Segmentation
    1. Therapeutic Class                     
      1. Introduction           
      2. Anti-inflammatory Drugs  
        1. Nonsteroidal Anti-inflammatory Drugs
        2. Steroids
      3. Anti-infective Drugs            
        1. Anti-fungal Drugs
        2. Anti-bacterial Drugs
        3. Others
      4. Anti-glaucoma Drugs          
        1. Alpha Agonist
        2. Beta Blockers
        3. Prostaglandin Analogs
        4. Combined Medication
        5. Others
      5. Anti-allergy Drugs
      6. Anti-VEGF Agents
      7. Others      
      8. Y-o-Y Growth Analysis, By Therapeutic Class            
      9. Market Attractiveness Analysis, By Therapeutic Class          
      10. Market Share Analysis, By Therapeutic Class         
    2. Product Type      
      1. Introduction           
      2. Prescription Drugs               
      3. Over-the-Counter Drugs   
      4. Y-o-Y Growth Analysis, By Product Type    
      5. Market Attractiveness Analysis, By Product Type  
      6. Market Share Analysis, By Product Type    
    3. Distribution Channel        
      1. Introduction           
      2. Hospital Pharmacies            
      3. Online  Pharmacies              
      4. Independent Pharmacies & Drug Stores    
      5. Y-o-Y Growth Analysis, By Distribution Channel      
      6. Market Attractiveness Analysis, By Distribution Channel    
      7. Market Share Analysis, By Distribution Channel     
    4. Disease Indications                 
      1. Introduction           
      2. Dry Eye     
      3. Glaucoma
      4. Infection/Inflammation     
      5. Retinal Disorders  
        1. Wet Age-related Macular Degeneration
        2. Dry Age-related Macular Degeneration
        3. Diabetic Retinopathy
        4. Others
      6. Allergy      
      7. Uveitis      
      8. Others      
      9. Y-o-Y Growth Analysis, By Disease Indications         
      10. Market Attractiveness Analysis, By Disease Indications    
      11. Market Share Analysis, By Disease Indications      
    5. Dosage Form      
      1. Introduction           
      2. Liquid Ophthalmic Drug Forms        
      3. Solid Ophthalmic Drug Forms          
      4. Semisolid Ophthalmic Drug Forms
      5. Multicompartment Drug Delivery Systems               
      6. Other Ophthalmic Drug Forms        
      7. Y-o-Y Growth Analysis, By Dosage Form     
      8. Market Attractiveness Analysis, By Dosage Form  
      9. Market Share Analysis, By Dosage Form   
    6. Technology                 
      1. Introduction           
      2. Biologics   
      3. Cell Therapy           
      4. Gene Therapy       
      5. Drug Delivery         
      6. Small molecule      
      7. Others      
      8. Y-o-Y Growth Analysis, By Technology        
      9. Market Attractiveness Analysis, By Technology      
      10. Market Share Analysis, By Technology     
  6. Geographical Analysis
    1. Introduction        
      1. Regional Trends    
      2. Impact Analysis     
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Therapeutic Class
        3. By Product Type
        4. By Distribution Channel
        5. By Disease Indication
        6. By Dosage Form
        7. By Technology
      4. Market Attractiveness Analysis     
        1. By Geographical Area
        2. By Therapeutic Class
        3. By Product Type
        4. By Distribution Channel
        5. By Disease Indication
        6. By Dosage Form
        7. By Technology
      5. Market Share Analysis      
        1. By Geographical Area
        2. By Therapeutic Class
        3. By Product Type
        4. By Distribution Channel
        5. By Disease Indication
        6. By Dosage Form
        7. By Technology
    2. U.K                 
    3. Spain      
    4. Germany                     
    5. Italy        
    6. France   
  7. Strategic Analysis                
    1. PESTLE analysis  
      1. Political     
      2. Economic 
      3. Social         
      4. Technological         
      5. Legal          
      6. Environmental       
    2. Porter’s Five analysis       
      1. Bargaining Power of Suppliers        
      2. Bargaining Power of Consumers    
      3. Threat of New Entrants     
      4. Threat of Substitute Products and Services              
      5. Competitive Rivalry within the Industry     
  8. Market Leaders' Analysis                 
    1. Abbott Medical Optics, Inc.                 
      1. Overview 
      2. Product Analysis   
      3. Financial analysis  
      4. Recent Developments       
      5. SWOT analysis       
      6. Analyst View          
    2. Carl-Zeiss AG      
    3. Ellex Medical Lasers Ltd.
    4. Essilor International S.A.
    5. Hoya Corporation                    
    6. Insight Vision Inc.                     
    7. Nidek Co.Ltd       
    8. Novagali Pharma S A        
    9. Topcon Corporation         
    10. Ziemer Ophthalmic Systems AG.                    
  9. Competitive Landscape                    
    1. Market share analysis     
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures  
    4. New Product Launches  
  10. Market Outlook and Investment Opportunities                  
  11. Appendix                    
    1. List of Tables                
    2. List of Figures       
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type and Packaged Containers along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Ophthalmic Drugs Market, By Disease Indication, From 2020 to 2025 (USD Billion)
  2. Europe Dry Eye Market, By Region, From 2020 to 2025 (USD Billion)
  3. Europe Glaucoma Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe Infection/Inflammation Market, By Region, From 2020 to 2025 (USD Billion)
  5. Europe Retinal Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  6. Europe Allergy Market, By Region, From 2020 to 2025 (USD Billion)
  7. Europe Uveitis Market, By Region, From 2020 to 2025 (USD Billion)
  8. Europe Others Market, By Region, From 2020 to 2025 (USD Billion)
  9. Europe Ophthalmic Drugs Market, By Therapeutic Class, From 2020 to 2025 (USD Billion)
  10. Europe Anti-inflammatory Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  11. Europe Anti-infective Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  12. Europe Anti-glaucoma Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  13. Europe Anti-allergy Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  14. Europe Anti-VEGF Agents Market, By Region, From 2020 to 2025 (USD Billion)
  15. Europe Others Market, By Region, From 2020 to 2025 (USD Billion)
  16. Europe Ophthalmic Drugs Market, By Product Type, From 2020 to 2025 (USD Billion)
  17. Europe Prescription Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  18. Europe Over-the-Counter Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  19. Europe Ophthalmic Drugs Market, By Distribution Channel, From 2020 to 2025 (USD Billion)
  20. Europe Hospital Pharmacies Market, By Region, From 2020 to 2025 (USD Billion)
  21. Europe Online Pharmacies Market, By Region, From 2020 to 2025 (USD Billion)
  22. Europe Independent Pharmacies & Drug Stores Market, By Region, From 2020 to 2025 (USD Billion)
  23. Europe Ophthalmic Drugs Market, By Dosage Form, From 2020 to 2025 (USD Billion)
  24. Europe Liquid Ophthalmic Drug Forms Market, By Region, From 2020 to 2025 (USD Billion)
  25. Europe Solid Ophthalmic Drug Forms Market, By Region, From 2020 to 2025 (USD Billion)
  26. Europe Semisolid Ophthalmic Drug Forms Market, By Region, From 2020 to 2025 (USD Billion)
  27. Europe Multicompartment Drug Delivery Systems Market, By Region, From 2020 to 2025 (USD Billion)
  28. Europe Other Ophthalmic Drug Forms Market, By Region, From 2020 to 2025 (USD Billion)
  29. Europe Ophthalmic Drugs Market, By Technology, From 2020 to 2025 (USD Billion)
  30. Europe Biologics Market, By Region, From 2020 to 2025 (USD Billion)
  31. Europe Cell Therapy Market, By Region, From 2020 to 2025 (USD Billion)
  32. Europe Gene Therapy Market, By Region, From 2020 to 2025 (USD Billion)
  33. Europe Drug Delivery Market, By Region, From 2020 to 2025 (USD Billion)
  34. Europe Small molecule Market, By Region, From 2020 to 2025 (USD Billion)
  35. Europe Others Market, By Region, From 2020 to 2025 (USD Billion)
  36. U.K. Ophthalmic Drugs Market, By Disease Indication, From 2020 to 2025 (USD Billion)
  37. U.K. Ophthalmic Drugs Market, By Therapeutic Class, From 2020 to 2025 (USD Billion)
  38. U.K. Ophthalmic Drugs Market, By Product Type, From 2020 to 2025 (USD Billion)
  39. U.K. Ophthalmic Drugs Market, By Distribution Channel, From 2020 to 2025 (USD Billion)
  40. U.K. Ophthalmic Drugs Market, By Dosage Form, From 2020 to 2025 (USD Billion)
  41. U.K. Ophthalmic Drugs Market, By Technology, From 2020 to 2025 (USD Billion)
  42. Germany Ophthalmic Drugs Market, By Disease Indication, From 2020 to 2025 (USD Billion)
  43. Germany Ophthalmic Drugs Market, By Therapeutic Class, From 2020 to 2025 (USD Billion)
  44. Germany Ophthalmic Drugs Market, By Product Type, From 2020 to 2025 (USD Billion)
  45. Germany Ophthalmic Drugs Market, By Distribution Channel, From 2020 to 2025 (USD Billion)
  46. Germany Ophthalmic Drugs Market, By Dosage Form, From 2020 to 2025 (USD Billion)
  47. Germany Ophthalmic Drugs Market, By Technology, From 2020 to 2025 (USD Billion)
  48. France Ophthalmic Drugs Market, By Disease Indication, From 2020 to 2025 (USD Billion)
  49. France Ophthalmic Drugs Market, By Therapeutic Class, From 2020 to 2025 (USD Billion)
  50. France Ophthalmic Drugs Market, By Product Type, From 2020 to 2025 (USD Billion)
  51. France Ophthalmic Drugs Market, By Distribution Channel, From 2020 to 2025 (USD Billion)
  52. France Ophthalmic Drugs Market, By Dosage Form, From 2020 to 2025 (USD Billion)
  53. France Ophthalmic Drugs Market, By Technology, From 2020 to 2025 (USD Billion)
  54. Italy Ophthalmic Drugs Market, By Disease Indication, From 2020 to 2025 (USD Billion)
  55. Italy Ophthalmic Drugs Market, By Therapeutic Class, From 2020 to 2025 (USD Billion)
  56. Italy Ophthalmic Drugs Market, By Product Type, From 2020 to 2025 (USD Billion)
  57. Italy Ophthalmic Drugs Market, By Distribution Channel, From 2020 to 2025 (USD Billion)
  58. Italy Ophthalmic Drugs Market, By Dosage Form, From 2020 to 2025 (USD Billion)
  59. Italy Ophthalmic Drugs Market, By Technology, From 2020 to 2025 (USD Billion)
  60. Spain Ophthalmic Drugs Market, By Disease Indication, From 2020 to 2025 (USD Billion)
  61. Spain Ophthalmic Drugs Market, By Therapeutic Class, From 2020 to 2025 (USD Billion)
  62. Spain Ophthalmic Drugs Market, By Product Type, From 2020 to 2025 (USD Billion)
  63. Spain Ophthalmic Drugs Market, By Distribution Channel, From 2020 to 2025 (USD Billion)
  64. Spain Ophthalmic Drugs Market, By Dosage Form, From 2020 to 2025 (USD Billion)
  65. Spain Ophthalmic Drugs Market, By Technology, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample